tifwp
-
Jul- 2023 -6 July
-
Apr- 2023 -19 April
-
Dec- 2022 -30 December
-
Nov- 2022 -14 NovemberNews
NEW APPROVAL | PYRUKYND® Gets EU Green Light For Pyruvate Kinase (PK) Deficiency
The European Commission has granted, on November 10, 2022, marketing authorization to Agios Pharmaceuticals for PYRUKYND® intended for the…
Read More » -
7 November
-
Sep- 2022 -14 September
-
1 September
-
Aug- 2022 -30 August
-
29 August
-
Mar- 2022 -1 MarchScientific Literature
Transfusion Complications in Thalassemia: Patient Knowledge and Perspectives
Chronic transfusion, used to manage clinically significant forms of thalassemia, carries complication risks including iron overload, alloimmunization, and allergic or…
Read More »
